Skip to content

Author

Xinyue Xu

We have 1 of 10 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Hyaluronic acid-decorated MOF nanoplatform loaded with berbamine elicits immunogenic ferroptosis through a sonodynamic/chemodynamic/chemotherapy synergy in triple-negative breast cancer.

Overall, the principal advance of this cascade nanoplatform lies in the coordinated integration of FeTCPP-mediated SDT, iron-dependent CDT, and BBM-associated ferroptosis sensitization within an HA-assisted MOF delivery system, providing a promising therapeutic strategy for TNBC.

Xinyue Xu, Chunyan Fang, Weiyi Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.